Page last updated: 2024-10-29

ketanserin and Breast Neoplasms

ketanserin has been researched along with Breast Neoplasms in 4 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"Therefore, the use of tropisetron and ketanserin as an antagonist of serotonin receptor may be as new approaches are recommended for the treatment of breast cancer cells."3.81Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line. ( Ahangari, G; Deezagi, A; Hejazi, SH, 2015)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Germain, AR1
Carmody, LC1
Nag, PP1
Morgan, B1
Verplank, L1
Fernandez, C1
Donckele, E1
Feng, Y1
Perez, JR1
Dandapani, S1
Palmer, M1
Lander, ES1
Gupta, PB1
Schreiber, SL1
Munoz, B1
Bai, C1
Ren, S1
Wu, S1
Zhu, M1
Luo, G1
Xiang, H1
Hejazi, SH1
Ahangari, G1
Deezagi, A1
Hughes, EW1
Hodkinson, BP1

Other Studies

4 other studies available for ketanserin and Breast Neoplasms

ArticleYear
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
    Bioorganic & medicinal chemistry letters, 2013, Mar-15, Volume: 23, Issue:6

    Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neopla

2013
Design and synthesis of novel benzothiophene analogs as selective estrogen receptor covalent antagonists against breast cancer.
    European journal of medicinal chemistry, 2021, Oct-05, Volume: 221

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Dose-Response

2021
Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line.
    Current drug discovery technologies, 2015, Volume: 12, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Gene Expression; Humans; Indoles; Ketanserin; MC

2015
Carcinoid syndrome: the combined use of ketanserin and octreotide in the management of an acute crisis during anaesthesia.
    Anaesthesia and intensive care, 1989, Volume: 17, Issue:3

    Topics: Anesthesia; Breast Neoplasms; Carcinoid Tumor; Female; Humans; Hypertension; Intraoperative Complica

1989